Business

Maite Malet, Asabys Partners director of investments and corporate development, discusses the Barcelona-based firm’s €180 million ($200 million) raise and its plans invest in 12 to 15 health tech companies to expand from the EU to the U.S.

The employer-focused hybrid care provider will use the funds to scale its operations and expand access to its preventative care model. 

The company will use the funds to scale its operations and further develop its technology as it aims to establish gait monitoring as a mainstream tool.

Malınka Walaliyadde, CEO and cofounder of AKASA, discusses the advancement and current views on artificial intelligence and tuning generative AI for use to improve the coding process in healthcare and revenue cycle management to support ROI.

The company's Synapsis AI platform automates complex data readings, which allows for more efficient and optimal clinical research.

The funding includes $4.5 billion for the firm's core VC funds, $1.5 billion for its Creation strategy and $2 billion for separately managed accounts.

The round was led by Andreessen Horowitz, which has announced two other significant digital health investments within the past two weeks.

Medical illustrator David Bolinsky, E.mersion Studios CEO and creative director, creates animations representing molecular and cellular biology, and says AI image generators’ hallucinations may affect scientific medical illustration.

The message-based platform allows patients to get answers to complex medical questions, receive second opinions, seek urgent care and obtain assistance with end-of-life decisions.

Jenn Kerfoot, chief strategy and growth officer at DUOS, discusses why only seven plans made five stars for Medicare Advantage Star Ratings, as opposed to 30 the previous year, and how plans can ensure a positive rating in the future.